معرفی
Beth Strellis is a Research Fellow in Molecular Biosciences at the University of Glasgow. She completed her PhD in Molecular Pharmacology in 2024 under Dr. Brian Hudson, focusing on receptor phosphorylation and mGlu5 metabotropic glutamate receptor signal transduction. Currently, she works under Professors Andrew Tobin and Graeme Milligan to explore the physiology of the free fatty acid receptor 4 (FFA4) in asthma and COPD. Her research spans receptor biology, neurodegenerative diseases, and respiratory pathophysiology.
- Education: BSc in Pharmacology at the University of Bristol.
Her research integrates molecular pharmacology and signal transduction to elucidate receptor roles in neurodegenerative and respiratory diseases. A 2021 article in Proceedings of the National Academy of Sciences examined M1 muscarinic receptor mutants in prion neurodegeneration, highlighting her interest in receptor signaling mechanisms.
Beth has presented at multiple conferences since 2021, including the British Pharmacological Society's meetings, World Congress of Basic & Clinical Pharmacology, and the School of Molecular Biosciences Conference. She served on the organisational committee for the Life Sciences ECR Symposium in 2023.
- Grants: Monitoring the Impact of FFA4 Activation on Inflammatory Lung Disease using Spatial Transcriptomic Analysis (NHS Greater Glasgow and Clyde Endowment Funds, 2025-2026).
She has supervised Honours and Masters students since 2021 and served as Demonstrator and Tutor for L1 Biology courses (2023-2024). Her lab is located at Lab 441, Advanced Research Centre, University of Glasgow.
